Literature DB >> 19240231

Rapid access to preventive intervention development program in the Division of Cancer Prevention of the U.S. National Cancer Institute: an overview.

Izet M Kapetanovic1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19240231      PMCID: PMC2679522          DOI: 10.1158/1055-9965.EPI-08-1007

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  13 in total

1.  Evaluation of cancer chemopreventive agents using clones derived from a human prostate cancer cell line.

Authors:  Jeffrey H Ware; Zhaozong Zhou; Levy Kopelovich; Ann R Kennedy
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

2.  Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.

Authors:  Clinton J Grubbs; Ronald A Lubet; Venkatram R Atigadda; Konstantin Christov; Anil M Deshpande; Vivek Tirmal; Gang Xia; Kirby I Bland; Isao Eto; Wayne J Brouillette; Donald D Muccio
Journal:  Carcinogenesis       Date:  2005-12-12       Impact factor: 4.944

3.  Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone.

Authors:  Richard D Verschoyle; Peter Greaves; Hong Cai; Arndt Borkhardt; Massimo Broggini; Maurizio D'Incalci; Ed Riccio; Rupa Doppalapudi; Izet M Kapetanovic; William P Steward; Andreas J Gescher
Journal:  Cancer Chemother Pharmacol       Date:  2005-11-05       Impact factor: 3.333

4.  Simultaneous determination of myristyl nicotinate, nicotinic acid, and nicotinamide in rabbit plasma by liquid chromatography-tandem mass spectrometry using methyl ethyl ketone as a deproteinization solvent.

Authors:  Paul Catz; Walter Shinn; Izet M Kapetanovic; Hyuntae Kim; Moonsun Kim; Elaine L Jacobson; Myron K Jacobson; Carol E Green
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-11-07       Impact factor: 3.205

5.  Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol.

Authors:  Thomas L Horn; Lina Long; Michael J Cwik; Robert L Morrissey; Izet M Kapetanovic; David L McCormick
Journal:  Chem Biol Interact       Date:  2005-04-15       Impact factor: 5.192

Review 6.  Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids).

Authors:  M B Sporn; N M Dunlop; D L Newton; J M Smith
Journal:  Fed Proc       Date:  1976-05-01

7.  Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone.

Authors:  David L McCormick; William D Johnson; Nicole M Kozub; K V N Rao; Ronald A Lubet; Vernon E Steele; Maarten C Bosland
Journal:  Carcinogenesis       Date:  2006-09-03       Impact factor: 4.944

8.  Evaluation of chemopreventive agents for genotoxic activity.

Authors:  Rupa S Doppalapudi; Edward S Riccio; Linda L Rausch; Julie A Shimon; Pam S Lee; Kristien E Mortelmans; Izet M Kapetanovic; James A Crowell; Jon C Mirsalis
Journal:  Mutat Res       Date:  2007-02-25       Impact factor: 2.433

9.  Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry.

Authors:  Gary H Posner; Heung Bae Jeon; Amy Sarjeant; Edward S Riccio; Rupa S Doppalapudi; Izet M Kapetanovic; Uttam Saha; Patrick Dolan; Thomas W Kensler
Journal:  Steroids       Date:  2004 Oct-Nov       Impact factor: 2.668

10.  Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.

Authors:  W D Johnson; R L Morrissey; I Kapetanovic; J A Crowell; D L McCormick
Journal:  Food Chem Toxicol       Date:  2007-11-12       Impact factor: 6.023

View more
  1 in total

1.  Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen.

Authors:  Rupa S Doppalapudi; Edward S Riccio; Zoe Davis; Sean Menda; Abraham Wang; Nicholas Du; Carol Green; Levy Kopelovich; Chinthalapally V Rao; Doris M Benbrook; Izet M Kapetanovic
Journal:  Mutat Res       Date:  2012-04-10       Impact factor: 2.433

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.